ONCOGENEX PHARMACEUTICALS INC (OGXI)

Overview Price 14.48 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $14.48 Daily Range $0.00 - $0.00 52-Week Range $8.63 - $18.99 Volume 0 ONCOGENEX PHARMACEUTICALS is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP-9222 and OGX-225 are currently in pre-clinical development. Other Resources for OGXI Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: The Zacks Analyst Blog Highlights: Dean Foods, Isis Pharmaceuticals, OncoGenex, GlaxoSmithKline and Sanofi-Aventis May 10, 2011 Zacks Blog: Isis Pharma Loss Widens May 9, 2011 ONCOGENEX PHARMACEUTICALS is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP-9222 and OGX-225 are currently in pre-clinical development.   Brokerage Analyst Recommendations 6 Brokerage Firms Covering OGXI   Strong Buy 4 Buy 2 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.33   OGXI Ratings: BUY  SELL  HOLD OGXI Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 2 Buy 0 Sell   Top Buy Analysis BUY: OGXI Company: ONCOGENEX PHARMACEUTICALS IN Points: -75.82 Start Price: $20.03 Start Date: 05/28/2009 1:11 PM george.ray P&P Score: 0.00 Recs: long term hold if trials go well Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	05/09/11	Isis Pharma Loss Widens - Analyst Blog	0
Zacks_Analysts	0.00	10/04/10	Teva's Oncology Drug Progresses - Analyst Blog	0
Zacks_Analysts	0.00	04/14/10	Teva Expands Oncology Pipeline - Analyst Blog	0
Zacks_Analysts	0.00	03/03/10	Isis Loss Widens - Analyst Blog	0
Zacks_Analysts	0.00	12/29/09	ISIS Gains from TEVA-OGXI Deal - Analyst Blog	0
Zacks_Analysts	0.00	12/28/09	Teva Expands Cancer Portfolio - Analyst Blog	0
Zacks_Analysts	0.00	06/24/09	Zacks Analyst Blog Highlights: Tiffany, Big Lots, Family Dollar, Isis Pharmaceuticals and OncoGenex - Press Releases	0
Zacks_Analysts	0.00	06/23/09	Isis Generating Impressive Data - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: ONCOGENEX PHARMACEUTICALS IN (OGXI) Start Price: $20.03 Points: -75.82 Created: 05/28/2009 long term hold if trials go well Comments: 0 | Comment george.ray Recs:

BUY: ONCOGENEX PHARMACEUTICALS IN (OGXI) Start Price: $13.27 Points: +3.30 Created: 08/03/2011 Comments: 0 | Comment dmonnie Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
dmonnie		BUY	One to Three Months	08/03/2011	$13.27	$14.67 (-4.55%)	+10.55%	+7.25%	+3.30
george.ray		BUY	One to Three Years	05/28/2009	$20.03	$14.67 (-4.55%)	-26.76%	+49.06%	-75.82	view close